Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.
Stradella A, Gargallo P, Cejuela M, Petit A, Bosch-Schips J, Carbonell P, Recalde S, Vethencourt A, Fernandez-Ortega A, Falo C, Gil-Gil M, Vázquez S, Obadia V, Villanueva-Vázquez R, Soler-Monsó T, Calabria I, Pernas S. Stradella A, et al. Among authors: falo c. Mod Pathol. 2022 Aug;35(8):1066-1074. doi: 10.1038/s41379-022-01017-7. Epub 2022 Feb 17. Mod Pathol. 2022. PMID: 35177782 Free article.
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA. Ruiz de Garibay G, et al. Among authors: falo c. PLoS One. 2015 Jul 13;10(7):e0132546. doi: 10.1371/journal.pone.0132546. eCollection 2015. PLoS One. 2015. PMID: 26167915 Free PMC article.
Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.
Garcia-Tejedor A, Falo C, Quetglas C, Soler T, Marqueta B, Ortega R, Gil-Gil M, Pernas S, Fernandez-Montolí E, Pla MJ, Guma A, Bajen M, Benitez A, Eraso A, Campos M, Petit A, Ponce J. Garcia-Tejedor A, et al. Among authors: falo c. Int J Surg. 2017 Mar;39:141-147. doi: 10.1016/j.ijsu.2017.01.106. Epub 2017 Jan 30. Int J Surg. 2017. PMID: 28153783 Free article.
The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
Fernandez-Gonzalez S, Falo C, Pla MJ, Pernas S, Bajen M, Soler T, Ortega R, Quetglas C, Perez-Martin X, Fernandez Montoli ME, Campos M, Varela-Rodriguez M, Ponce J, Garcia-Tejedor A. Fernandez-Gonzalez S, et al. Among authors: falo c. Clin Breast Cancer. 2018 Feb;18(1):71-77. doi: 10.1016/j.clbc.2017.08.014. Epub 2017 Sep 4. Clin Breast Cancer. 2018. PMID: 29030106
Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial.
García-Tejedor A, Guma A, Soler T, Valdivieso A, Petit A, Contreras N, Chappuis CG, Falo C, Pernas S, Amselem A, Plà MJ, Fernández-Montolí E, Burdío F, Ponce J. García-Tejedor A, et al. Among authors: falo c. Radiology. 2018 Nov;289(2):317-324. doi: 10.1148/radiol.2018180235. Epub 2018 Aug 21. Radiology. 2018. PMID: 30129904 Clinical Trial.
Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M, Soler-Monsó T, Petit A, Azcarate J, Lasheras A, Artal C, Gil M, Falo C, Pla MJ, Matias-Guiu X. Del Rosario Taco Sanchez M, et al. Among authors: falo c. Virchows Arch. 2019 Feb;474(2):169-176. doi: 10.1007/s00428-018-2481-3. Epub 2018 Nov 21. Virchows Arch. 2019. PMID: 30465110
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
Pernas S, Petit A, Climent F, Paré L, Perez-Martin J, Ventura L, Bergamino M, Galván P, Falo C, Morilla I, Fernandez-Ortega A, Stradella A, Rey M, Garcia-Tejedor A, Gil-Gil M, Prat A. Pernas S, et al. Among authors: falo c. Front Oncol. 2019 Aug 6;9:707. doi: 10.3389/fonc.2019.00707. eCollection 2019. Front Oncol. 2019. PMID: 31448227 Free PMC article.
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
Pernas S, Petit A, Climent F, Paré L, Perez-Martin J, Ventura L, Bergamino M, Galván P, Falo C, Morilla I, Fernandez-Ortega A, Stradella A, Rey M, Garcia-Tejedor A, Gil-Gil M, Prat A. Pernas S, et al. Among authors: falo c. Front Oncol. 2019 Sep 25;9:967. doi: 10.3389/fonc.2019.00967. eCollection 2019. Front Oncol. 2019. PMID: 31598491 Free PMC article.
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.
Sirvén MB, Fernández-Ortega A, Stradella A, Morilla I, Falo C, Vázquez S, Castany R, Villanueva R, Recalde S, Pérez VN, Gil-Gil M, Pernas S. Sirvén MB, et al. Among authors: falo c. BMC Pharmacol Toxicol. 2019 Nov 21;20(1):68. doi: 10.1186/s40360-019-0367-x. BMC Pharmacol Toxicol. 2019. PMID: 31753013 Free PMC article.
Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy.
Fernandez-Gonzalez S, Falo C, Pla MJ, Verdaguer P, Nuñez D, Guma A, Soler T, Vethencourt A, Vázquez S, Fernandez-Montoli ME, Campos M, Pernas S, Gil M, Ponce J, Garcia-Tejedor A. Fernandez-Gonzalez S, et al. Among authors: falo c. Breast J. 2020 May;26(5):888-896. doi: 10.1111/tbj.13763. Epub 2020 Feb 13. Breast J. 2020. PMID: 32052521
56 results